PHCCC 50mg | ≥99%
CSNpharm
PHCCC is a Group I metabotropic glutamate receptor antagonist with EC 50 of 6 μM and a positive allosteric modulator of mGluR4.
More Information Supplier Page
PHCCC is a Group I metabotropic glutamate receptor antagonist with EC 50 of 6 μM and a positive allosteric modulator of mGluR4.
More Information Supplier Page
Reserpine HCl is a naturally occuring brain-penetrant and irreversible VMAT (vesicular monoamine transporter 1 and 2) antagonist.
More Information Supplier Page
Reserpine HCl is a naturally occuring brain-penetrant and irreversible VMAT (vesicular monoamine transporter 1 and 2) antagonist.
More Information Supplier Page
Adelmidrol is an ethanolamide derivative of azelaic acid with anti-inflammatory properties partly dependent on PPARγ, it also markedly reduce pro-inflammatory NF-κB pathway.
More Information Supplier Page
Adelmidrol is an ethanolamide derivative of azelaic acid with anti-inflammatory properties partly dependent on PPARγ, it also markedly reduce pro-inflammatory NF-κB pathway.
More Information Supplier Page
XY1 is a negative control of SGC 707 which works as a potent and selective allosteric inhibitor of PRMT3, while XY1 shows almost no activity.
More Information Supplier Page
XY1 is a negative control of SGC 707 which works as a potent and selective allosteric inhibitor of PRMT3, while XY1 shows almost no activity.
More Information Supplier Page
XY1 is a negative control of SGC 707 which works as a potent and selective allosteric inhibitor of PRMT3, while XY1 shows almost no activity.
More Information Supplier Page
Sitafloxacin Hydrate is a fluoroquinolone antibiotic with promising effect on the treatment of Buruli ulcer.
More Information Supplier Page
Sitafloxacin Hydrate is a fluoroquinolone antibiotic with promising effect on the treatment of Buruli ulcer.
More Information Supplier Page